IMAC Holdings, Inc. has launched Ignite Proteomics LLC, a new subsidiary focused on enhancing cancer treatment personalization through protein-level analysis. This initiative aims to improve the ...

Ignite Proteomics LLC announced the publication of a pivotal study in the British Journal of Cancer, which emphasizes the importance of measuring activated proteins in the AKT–mTOR signaling pathway ...

SAMBAI, a team funded through the Cancer Grand Challenges initiative, reported that Akoya Biosciences’ PhenoCycler ®-Fusion system will be the foundational spatial proteomics technology used to ...

Nashville, TN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (BACK) (“IMAC Holdings” or the “Company”) has launched Ignite Proteomics LLC (“Ignite”), its new subsidiary dedicated to helping ...

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing high sensitivity and specificity, explains Justin Drake, PhD. Current standard ...

MARLBOROUGH, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, and SAMBAI, a team funded through the Cancer Grand Challenges initiative, ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

A new study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...

OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...

Technology Networks recently spoke with Dr. Birgit Schilling, a professor at the Buck Institute for Research on Aging, to learn how she is using proteomics to decode the molecular signatures of aging ...